RxDoctor Payments DataLook up a doctor →

Kelly Greene, MD

Critical Care Medicine · Littleton, CONPI 1790857340

Payments from drug & device makers

$17,942in general payments, 2019–2025

Across 413 payments — averaging $43.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$11K
  • AstraZeneca$2K
  • Regeneron Healthcare Solutions, Inc.$756
  • Sanofi$670
  • Grifols USA, LLC$468
  • Boehringer Ingelheim$244
  • plus $3K from 38 others

What the payments were for

  • Consulting fees$9,42553%
  • Food & beverage$8,48147%
  • Education$360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,942 in reported general payments places this provider in the 85th percentile of 141 critical care medicine providers in Colorado.

See all critical care medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$164,205
Medicare patients
412
Services billed
1,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter397$366,313
Breztri AerosphereBudesonide/Glycopyr/Formoterol99$82,353
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr45$21,606
EliquisApixaban30$19,188
Breo ElliptaFluticasone/Vilanterol28$17,338
SymbicortBudesonide/Formoterol Fumarate40$12,054
Albuterol Sulfate HfaAlbuterol Sulfate65$1,442
Azithromycin44$271
Prednisone70$211
Montelukast Sodium20$129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$10,840$405,256470 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,370$94,407139 claims
PfizerEliquis$84$19,18830 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 141 critical care medicine providers in Colorado.

Other critical care medicine in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →